Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-29.47	33.07	46.89
Graham Fair Price	41.42	11.35	8.03
PEG	-43.67	0.67	-1.19
Price/Book	25.38	1.51	1.21
Price/Cash Flow	-37.11	9.62	15.30
Prices/Earnings	-37.31	70.47	112.40
Price/Sales	-45.74	1.00	1.85
Price/FCF	-37.11	9.62	15.30
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	87.08	0.10	0.05
Operating Margin	-28.55	0.02	0.02
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	65.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.18	100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.81	0.65	-64.00
EPS QOQ	-0.95	1.05	11.28
FCF QOQ	2.35	0.99	-57.68
Revenue QOQ	-0.52	1.31	151.74
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	116.49	53.09	-54.43
Days Sales Outstanding (DSO)	99.44	47.69	-52.04
Inventory Turnover	0.77	1.70	119.43
Debt/Capitalization	0.35	0.35	0.00
Quick Ratio	1.52	1.00	-34.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	32.67	32.67	< 0.005
Cash	23.24	23.54	1.28
Capex	0.00	-0.02	-100.00
Free Cash Flow	2.57	5.13	99.38
Revenue	21.29	49.19	131.08
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.69	1.66	-38.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.91	-1.06	44.21
Naive Interpretation	Member

06 - Financial Health · Weak

Rating